ZEST yields 1148.77% · JNJ yields 2.13%● Live data
📍 ZEST pulled ahead of the other in Year 1
Combined, ZEST + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZEST + JNJ for your $10,000?
Ecoark Holdings, Inc., through its subsidiaries, engages in the oil and gas, bitcoin mining, and post-harvest shelf-life and freshness food management technology businesses in the United States. It engages in the exploration, production, and drilling of oil and gas properties in Texas, Louisiana, and Mississippi, as well as offers transportation of frac sand and logistics services to hydraulic fracturing and drilling operations. The company also provides freshness management solutions for fresh food growers, suppliers, processors, distributors, grocers, and restaurants. In addition, it offers Zest Fresh solution, a cloud-based post-harvest shelf-life and freshness management solution that matches customer freshness requirements with actual product freshness and reduces post-harvest losses; and Zest Delivery solution, which provides real-time monitoring and control for prepared food delivery containers and helps delivery and dispatch personnel to ensure the quality and safety of delivered food. Further, the company is involved in the bitcoin mining operations; and procures and finances equipment to oilfield transportation service contractors. Ecoark Holdings, Inc. was founded in 2011 and is headquartered in San Antonio, Texas.
Full ZEST Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.